Medistim ASA (LON:0OCD)

Market Cap	309.46M +58.9%
Revenue (ttm)	49.32M +22.2%
Net Income	10.61M +40.1%
EPS	0.58 +40.3%
Shares Out	n/a
PE Ratio	29.17
Forward PE	25.13
Dividend	0.44 (0.18%)
Ex-Dividend Date	May 9, 2025

Volume	193
Average Volume	413
Open	224.00
Previous Close	229.50
Day's Range	224.00 - 224.50
52-Week Range	151.00 - 288.00
Beta	1.15
RSI	35.87
Earnings Date	Feb 27, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0OCD

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK